Sichuan Huiyu Pharmaceutical Co., Ltd.

SSE:688553.SS

16.09 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 00162.13918.77846.43650.84620.23830.30738.39513.62865.6650.509119.19358.791129.448122.958134.66275.612105.56689.11473.032
Depreciation & Amortization 00018.7818.7816.608-31.07815.68415.68414.85214.85211.70511.70541.127-18.69618.69600000
Deferred Income Tax 00000000030.95436.495-16.842000000000
Stock Based Compensation 0002.45701.7550000.478-0.3620.362000000000
Change In Working Capital 000-14.1540-9.47153.694-53.6940-32.65614.676-14.6760-100.06169.461-69.46100000
Accounts Receivables 000-5.5640-23.93669.83-69.830-41.608-2.4032.4030-23.85744.752-44.75200000
Change In Inventory 000-8.59010.56-16.13616.13608.95217.079-17.0790-87.03824.708-24.70800000
Change In Accounts Payables 000000000000000000000
Other Working Capital 000003.905000-1.57400010.8340000000
Other Non Cash Items 00-33.56935.052-30.64727.609-84.062138.019-15.684-13.628-65.6619.451-119.193-58.791-129.448-122.958-134.662-75.612-105.566-89.114-73.032
Operating Cash Flow 00128.5735.0515.78961.847-41.208130.31538.39513.62865.6650.509-093.697138.77771.212142.67838.974179.095109.47360.406
Investing Activities:
Investments In Property Plant And Equipment -38.596-17.383-26.666-23.465-60.668-51.508-61.906-88.85-94.456-124.439-121.021-151.779-64.375-105.269-133.345-82.182-112.657-56.052-35.508-21.555-45.125
Acquisitions Net 000.080.00601.03600.0010.002-0.0070.006-000.002133.34582.182112.65756.05235.50821.55545.125
Purchases Of Investments -190-246.979-280-352.931-320.105-1,128-535-579-1,387-1,501-1,046.85-1,243.15-1,182-1,857-1,139.6-1,315-1,428.5-970.5-1,370-1,262.5-913
Sales Maturities Of Investments 41.1400.391256.771521.0424181,085.735601.797987.9851,468.0461,344.9461,329.7591,449.651,134.223351.6761,409.7961,423.9851,115.9731,323.994976.7171,386762.413
Other Investing Activites -00.013-6.7710.006100.246-26.76366.797-00-5-0206.50.0010.002-133.345-82.182-112.657-57.023-34.537-22.525-45.125
Investing Cash Flow -187.496136.042-56.586144.65337.227-92.7374.891320.136-13.408-285.499161.89454.722-112.151-1,610.592136.85126.802-425.184296.471-427.82100.975-195.712
Financing Activities:
Debt Repayment -113.9-94.5669.5660165.50267-45114.5000-5013.054000-500-35
Common Stock Issued 0000000000000-19.2340000000
Common Stock Repurchased 00000-1000000000000000
Dividends Paid -1.886-3.216-2.73-89.793-2.397-99.509-99.509-99.509-0.319-1.805-91.794-0.008-0.163-0.17-0.198-0.162-0.16-0.184-0.2-0.213-1.278
Other Financing Activities 58.204-21.623-0.594-15.229-31.218-117.081-010-4.322044.4910.1632,333.88501.1-0.1-0.099-0.0010-7.317
Financing Cash Flow -57.582-119.4056.243-105.022131.885-115.147266.589-144.324114.181-2.516-91.79444.483-50.1632,346.768-0.1980.938-0.26-5.283-0.2-0.213-43.595
Other Information:
Effect Of Forex Changes On Cash 000001.641-6.797-5.989-94.169-61.47232.846-17.87397.6920.06-0.126-0.0220.0450.084-0.0080.117-0.384
Net Change In Cash -242.51697.41478.22766.638184.9018.015223.476300.13844.999-335.86168.606131.841-64.622829.934275.30498.931-282.721330.246-248.933210.352-179.285
Cash At End Of Period 1,814.7282,057.2441,959.831,881.6031,967.381,782.4791,774.461,550.9851,250.8471,205.8451,541.7051,373.0991,241.2571,292.97463.036187.73288.801371.52241.276290.20979.857